GRCE Buy Disclosure
Opaleye Management Inc. · SEC Form 4 · Filed Oct 21, 2026
Buy
Calculated transaction value
$8K
Opaleye Management Inc. 10% owner
GRCE
Grace Therapeutics
GRCE
Transaction date
Oct 19, 2026
Public filing date
Oct 21, 2026
Filing lag
Filed 2 days later
GRCE daily price context
Close on/before transaction
$1.88
Oct 19, 2026
First close after public filing
$1.92
Oct 22, 2026
Return after filing · so far
-3.8%
Through Nov 10, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock, par value $0.0001 per share
- Quantity / price
- 4,256 shares @ $1.88
- SEC ownership
- Indirect
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001493152-26-047949
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$8K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Grace Therapeutics, Inc. GRCE Current | Buy | Oct 19, 2026 | $8K |